Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (vi) New inpatient clients, primary drug distribution by age (%)

Substance	<15	15–19	20–24	25–29	30–34	35–39	40–44	45+	Age known	Age not known
Opioids	3.9	20.9	42.0	56.3	55.0	58.2	48.6	29.1	3911	7
Cocaine	2.0	2.8	7.6	8.8	9.1	11.7	13.6	6.4	703	2
Stimulants	11.8	20.6	17.4	11.7	11.7	5.9	7.6	8.9	1124	5
Hypnotics and sedatives	2.0	2.0	2.2	2.3	3.8	5.0	12.1	29.1	495	5
Hallucinogens	0.0	0.4	0.5	0.6	0.4	0.4	0.0	0.0	34	0
Volatile substances	23.5	9.6	1.5	1.5	1.3	0.6	0.0	0.4	202	0
Cannabis	51.0	41.3	26.0	16.4	16.2	14.2	13.2	11.9	1815	7
Other substances	5.9	2.4	2.8	2.4	2.4	4.0	4.9	14.0	330	0
Total	51	1089	1924	2034	1406	796	552	762	8614	26

Notes:

 The countries supplying data are: 

 AT; BE; BG; HR; CY; CZ; DK; FI; FR; DE; GR; HU; IE; NL; PL; RO; SK; SE; TR; UK. 

 The number of treatment clients in each country is listed in Table TDI-7. 

 See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2010 — Table TDI outpatient and inpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)